Lanthanides in medicine are advancing from research to FDA review, with novel cancer treatments and kidney therapies nearing clinical approval. Highlights Lanthanide-based therapeutics are rapidly advancing from academic research to clinical reality, with AGuIX gadolinium nanoparticles completing Phase 2 trials for brain cancer and Unicycive's oxylanthanum carbonate awaiting FDA approval in ... [14174 chars]